Phase I trial with 177Lu-DOTA-TATE and olaparib in somatostatin receptor positive tumours

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512463-31-00

Enrollment

Registered

2024-10-23

Start date

2024-10-27

Completion date

Unknown

Last updated

2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Somatostatin receptor positive tumours

None listed

Sex/Gender

All

Age

18 Years to No maximum

Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026